Engaging digital experiences for clinical trials
We design and build compliant, custom digital experiences for clinical trials. Engaging digital experiences lead to better patient compliance, more complete clinical trial data, and ultimately faster time to market for life-changing treatments.


Unmatched, tech-agnostic eCOA and ePRO expertise
Our deep understanding of digital health extends beyond platforms. We have tested and refined our services over thousands of clinical trials, hundreds of instruments, and multiple therapeutic areas. Being tech agnostic means we can configure and customize any platform to meet the specific needs of your study.
We also leverage our extensive eCOA and ePRO experience to provide custom solutions that meet regulatory rigor, drive high patient engagement, and increase speed to market.

Our five ingredients of engagement
Patient retention and compliance is imperative to the integrity of your clinical trial data. With our industry expertise, we established five ingredients to engage patients as part of The Studion Way.
Our end-to-end services
We approach Life Sciences holistically, from strategy through the growth of each program, with experts working across phases to help you scale your success.

Study Enablement
- Rich digital experiences designed, delivered, and tested for patient, caregivers, and sites
- Custom development and integrations
- Validated instrument libraries

Testing and Validation
- Customized study-level validation
- User acceptance testing packages
- Independent test development and execution

Technical Risk Mitigation
- Vendor assessment and selection
- Platform assessments for technical configuration and compliance
- Customized trial risk mitigation assessments

Flexible Bench
- Individuals, teams, or squads to deploy as needed for
- Project Management
- Design
- Development
- Testing
- Quality Management
- Training
Our experience

0+
Trials

0+
Therapeutic Areas

0+
Platforms

0+
Years
We’re proud of our partnerships

“Studion’s Life Sciences practice really understands the complexity of building technology in clinical trials and as a truly great partner provides innovative thinking to help us streamline our approach”
— Craig Gravina, Chief Technology Officer at ObvioHealth